4//SEC Filing
MUTO FREDERICK T 4
Accession 0000874015-19-000100
CIK 0000874015other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:43 PM ET
Size
25.3 KB
Accession
0000874015-19-000100
Insider Transaction Report
Form 4
MUTO FREDERICK T
Director
Transactions
- Exercise/Conversion
Common Stock
2019-07-03+667→ 12,683 total - Exercise/Conversion
Restricted Stock Units
2019-07-01−667→ 666 total→ Common Stock (667 underlying) - Exercise/Conversion
Restricted Stock Units
2019-07-03−667→ 1,333 total→ Common Stock (667 underlying) - Award
Director Stock Option (right to buy)
2019-07-01+16,000→ 16,000 totalExercise: $64.80From: 2020-07-01Exp: 2029-06-30→ Common Stock (16,000 underlying) - Exercise/Conversion
Common Stock
2019-07-02+889→ 12,016 total - Award
Restricted Stock Units
2019-07-01+7,110→ 7,110 total→ Common Stock (7,110 underlying) - Exercise/Conversion
Common Stock
2019-07-01+666→ 10,460 total - Exercise/Conversion
Common Stock
2019-07-01+667→ 11,127 total - Exercise/Conversion
Restricted Stock Units
2019-07-01−666→ 0 total→ Common Stock (666 underlying) - Exercise/Conversion
Restricted Stock Units
2019-07-02−889→ 2,666 total→ Common Stock (889 underlying)
Holdings
- 1,500(indirect: By Cooley LLP Sal Def & PSP u/A DTD 2/1/74 Pension Plan)
Common Stock
Footnotes (5)
- [F1]Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F3]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- [F4]Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019.
- [F5]Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181560
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 6:43 PM ET
- Size
- 25.3 KB